Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials.

@article{Webster2004Interleukin2R,
  title={Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials.},
  author={Angela C Webster and Elliott Geoffrey Playford and Gail E Higgins and Jeremy Robert Chapman and Jonathan C Craig},
  journal={Transplantation},
  year={2004},
  volume={77 2},
  pages={166-76}
}
BACKGROUND Interleukin 2 receptor antagonists (IL-2Ra) are increasingly used to treat renal transplant recipients. This study aims to systematically identify and summarize the effects of using IL-2Ra as induction immunosuppression, as an addition to standard therapy, or as an alternative to other antibody therapy. METHODS Databases, reference lists, and abstracts of conference proceedings were searched extensively to identify relevant randomized controlled trials in all languages. Data were… CONTINUE READING